Cell and Gene therapies started a new area of patient centric treatments in the life sciences industry. These therapies lay the foundation for a different way of thinking in the industry by providing new possibility while raising the bar for the supply of these therapies.
We at Tenthpin have developed a cell and gene therapy supply management solution based on SAP S/4 HANA. We understand the effort required for a holistic end-to-end supply chain, taking in to account the diverse supply possibilities. What we discovered is not just how to set up the end-to-end supply chain for the cell and gene therapies but also identified the key business decisions that come with designing the supply chain.
What supply challenges has the industry learned after witnessing these groundbreaking therapies transform the healthcare sector?
It is imperative to understand the balance between automation and flexibility while adhering to the overall internal strategy. Tenthpin supports the life science industry by designing the right solution according to the product portfolio and building an effective strategy to deliver a balanced cell and gene therapy supply chain.